238 related articles for article (PubMed ID: 25533385)
1. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells.
Ichioka M; Mita S; Shimizu Y; Imada K; Kiyono T; Bono Y; Kyo S
J Steroid Biochem Mol Biol; 2015 Mar; 147():103-10. PubMed ID: 25533385
[TBL] [Abstract][Full Text] [Related]
2. Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β.
Mita S; Shimizu Y; Sato A; Notsu T; Imada K; Kyo S
Fertil Steril; 2014 Feb; 101(2):595-601. PubMed ID: 24289989
[TBL] [Abstract][Full Text] [Related]
3. Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.
Yamanaka K; Xu B; Suganuma I; Kusuki I; Mita S; Shimizu Y; Mizuguchi K; Kitawaki J
Fertil Steril; 2012 Feb; 97(2):477-82. PubMed ID: 22130322
[TBL] [Abstract][Full Text] [Related]
4. Does dienogest influence the inflammatory response of endometriotic cells? A systematic review.
Grandi G; Mueller M; Bersinger NA; Cagnacci A; Volpe A; McKinnon B
Inflamm Res; 2016 Mar; 65(3):183-92. PubMed ID: 26650031
[TBL] [Abstract][Full Text] [Related]
5. Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system.
Shimizu Y; Mita S; Takeuchi T; Notsu T; Mizuguchi K; Kyo S
Steroids; 2011 Jan; 76(1-2):60-7. PubMed ID: 20851710
[TBL] [Abstract][Full Text] [Related]
6. Dienogest reduces HSD17β1 expression and activity in endometriosis.
Mori T; Ito F; Matsushima H; Takaoka O; Koshiba A; Tanaka Y; Kusuki I; Kitawaki J
J Endocrinol; 2015 May; 225(2):69-76. PubMed ID: 25767055
[TBL] [Abstract][Full Text] [Related]
7. Dienogest inhibits C-C motif chemokine ligand 20 expression in human endometriotic epithelial cells.
Mita S; Nakakuki M; Ichioka M; Shimizu Y; Hashiba M; Miyazaki H; Kyo S
Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():65-70. PubMed ID: 28482330
[TBL] [Abstract][Full Text] [Related]
8. Progestin effects on expression of AKR1C1-AKR1C3, SRD5A1 and PGR in the Z-12 endometriotic epithelial cell line.
Beranič N; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):218-25. PubMed ID: 23183084
[TBL] [Abstract][Full Text] [Related]
9. Dienogest mediates midkine suppression in endometriosis.
Nirgianakis K; Grandi G; McKinnon B; Bersinger N; Cagnacci A; Mueller M
Hum Reprod; 2016 Sep; 31(9):1981-6. PubMed ID: 27412246
[TBL] [Abstract][Full Text] [Related]
10. Drospirenone reduces inflammatory cytokines, vascular endothelial growth factor (VEGF) and nerve growth factor (NGF) expression in human endometriotic stromal cells.
Makabe T; Koga K; Miyashita M; Takeuchi A; Sue F; Taguchi A; Urata Y; Izumi G; Takamura M; Harada M; Hirata T; Hirota Y; Wada-Hiraike O; Fujii T; Osuga Y
J Reprod Immunol; 2017 Feb; 119():44-48. PubMed ID: 28064076
[TBL] [Abstract][Full Text] [Related]
11. Dienogest: a new therapeutic agent for the treatment of endometriosis.
Harada T; Taniguchi F
Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868
[TBL] [Abstract][Full Text] [Related]
12. Lack of stimulatory effect of dienogest on the expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by endothelial cell as compared with other synthetic progestins.
Tatsumi H; Kitawaki J; Tanaka K; Hosoda T; Honjo H
Maturitas; 2002 Aug; 42(4):287-94. PubMed ID: 12191851
[TBL] [Abstract][Full Text] [Related]
13. Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases.
Morales-Prieto DM; Herrmann J; Osterwald H; Kochhar PS; Schleussner E; Markert UR; Oettel M
Reprod Biol; 2018 Sep; 18(3):252-258. PubMed ID: 30001982
[TBL] [Abstract][Full Text] [Related]
14. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study.
Grandi G; Xholli A; Napolitano A; Palma F; Cagnacci A
Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646
[TBL] [Abstract][Full Text] [Related]
15. Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis.
Maeda N; Izumiya C; Taniguchi K; Matsushima S; Mita S; Shimizu Y; Fukaya T
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():48-51. PubMed ID: 24793935
[TBL] [Abstract][Full Text] [Related]
16. Dienogest in the treatment of endometriosis.
Bizzarri N; Remorgida V; Leone Roberti Maggiore U; Scala C; Tafi E; Ghirardi V; Salvatore S; Candiani M; Venturini PL; Ferrero S
Expert Opin Pharmacother; 2014 Sep; 15(13):1889-902. PubMed ID: 25069386
[TBL] [Abstract][Full Text] [Related]
17. Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells.
Grandi G; Mueller M; Bersinger N; Papadia A; Nirgianakis K; Cagnacci A; McKinnon B
Am J Reprod Immunol; 2016 Oct; 76(4):292-8. PubMed ID: 27515307
[TBL] [Abstract][Full Text] [Related]
18. Progesterone and synthetic progestin, dienogest, induce apoptosis of human primary cultures of adenomyotic stromal cells.
Yamanaka A; Kimura F; Kishi Y; Takahashi K; Suginami H; Shimizu Y; Murakami T
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():170-4. PubMed ID: 24953822
[TBL] [Abstract][Full Text] [Related]
19. Identification of biomarkers for drug-resistant endometriosis using clinical proteomics.
Kobayashi Y; Fukutomi T; Mita S; Watanabe M; Suzuki A
Hum Cell; 2021 Mar; 34(2):394-399. PubMed ID: 33387360
[TBL] [Abstract][Full Text] [Related]
20. The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis.
Grandi G; Mueller MD; Bersinger NA; Facchinetti F; McKinnon BD
Gynecol Endocrinol; 2017 Sep; 33(9):712-715. PubMed ID: 28412861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
